Solid Biosciences (SLDB) Revenue (2021 - 2022)
Solid Biosciences' Revenue was $8.09 million in FY2022, down 40.6% from $13.62 million in FY2021.
Powered by 
Analysis
Solid Biosciences (SLDB) Revenue (2021 - 2022) Analysis & Trends
- Per Business Quant data, Revenue in earlier years was $13.62 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,139.37 Bn | 1,107.95 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 618.39 Bn | 536.92 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 508.07 Bn | 481.19 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 367.07 Bn | 321.44 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.65 Bn | 262.64 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 263.08 Bn | 236.77 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 236.65 Bn | 192.05 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 192.73 Bn | 166.92 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Solid Biosciences | 941.16 Mn | -241.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 6.17 Mn |
| Jun 30, 2021 | -13,000.00 |
| Mar 31, 2021 | -14,000.00 |
API Access
Solid Biosciences Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=SLDB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "SLDB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=SLDB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();